BSECompany Update24 Aug 2026 · 24 Aug 2026, 04:03 pm
As Attached
Eris Lifesciences Ltd · 540596
✦ AI SummaryMgmt Change
Eris Lifesciences Ltd has announced an analyst/institutional investor meeting with HBM Partners AG on August 27, 2026, to discuss publicly available documents.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
72ac27ab-1ef4-4f04-8382-ecef0d120739.pdf
View document text
Date: 24 August 2026
To To
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza
Dalal Street Bandra Kurla Complex
Mumbai – 400001 Bandra (E)
Mumbai – 400051
Security Code: 540596 Symbol: ERIS
SUBJECT: INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING
Dear Sir/Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we
wish to inform you that the Management of Eris Lifesciences Limited will be meeting with the following
institutional investor:
Management Mode of
Day and Date Fund Name Meeting Details
Representatives Meeting
Thursday, 10:30 AM IST,
HBM Partners AG Mr. Amit Bakshi In Person
Aug 27, 2026 1X1
The above schedule is indicative and is subject to changes necessitated by any unforeseen developments.
The company will be referring to publicly available documents for discussions during interaction in the meeting
and no unpublished price sensitive information (UPSI) is intended to be discussed during the interaction.
Thanking You,
For Eris Lifesciences Limited
Milind Talegaonkar
Company Secretary & Compliance Officer
Membership No: A26493